Literature DB >> 11706946

Expression and regulation of MMP-20 in human tongue carcinoma cells.

A Väänänen1, R Srinivas, M Parikka, H Palosaari, J D Bartlett, K Iwata, R Grenman, U H Stenman, T Sorsa, T Salo.   

Abstract

Human matrix metalloproteinase-20 (MMP-20, enamelysin) fragments the enamel-specific protein amelogenin and has been shown to be synthesized exclusively by odontoblasts and ameloblasts and in certain odontogenic tumors. Here we demonstrate, for the first time, the expression of MMP-20 mRNA and protein in two carcinoma cell lines originating from the tongue. Treatment of the SCC-25 and HSC-3 cells with phorbol 12-myristate 13-acetate (10 nmol/L) up-regulated MMP-20 mRNA and protein expression by up to 1.6-fold, but transforming growth factor beta (10 ng/mL) had no effect. The latent proform of recombinant (r) human MMP-20 was converted by tumor-related trypsin-2. Activated rMMP-20 did not degrade type I or type II collagen, but efficiently hydrolyzed fibronectin, type IV collagen, laminin-1 and -5, tenascin-C, and beta-casein. This implies that MMP-20 not only participates in dental matrix remodeling but is also present in tongue carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706946     DOI: 10.1177/00220345010800100501

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  11 in total

1.  Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.

Authors:  Hyesook Yoon; Sachiko I Blaber; Wu Li; Isobel A Scarisbrick; Michael Blaber
Journal:  Biol Chem       Date:  2013-01       Impact factor: 3.915

2.  Type IV collagen is a novel DEJ biomarker that is reduced by radiotherapy.

Authors:  J D McGuire; J P Gorski; V Dusevich; Y Wang; M P Walker
Journal:  J Dent Res       Date:  2014-08-21       Impact factor: 6.116

3.  Matrix metalloproteinase 20 promotes a smooth enamel surface, a strong dentino-enamel junction, and a decussating enamel rod pattern.

Authors:  John D Bartlett; Ziedonis Skobe; Antonio Nanci; Charles E Smith
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

4.  Extracts of irradiated mature human tooth crowns contain MMP-20 protein and activity.

Authors:  J D McGuire; A A Mousa; Bo J Zhang; L S Todoki; N T Huffman; K B Chandrababu; J Moradian-Oldak; A Keightley; Y Wang; M P Walker; J P Gorski
Journal:  J Dent       Date:  2014-03-04       Impact factor: 4.379

5.  Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.

Authors:  Yan Wang; Yuanqing Ye; Jie Lin; Larissa Meyer; Xifeng Wu; Karen Lu; Dong Liang
Journal:  Mol Carcinog       Date:  2013-11-19       Impact factor: 4.784

6.  MMP-20 is predominately a tooth-specific enzyme with a deep catalytic pocket that hydrolyzes type V collagen.

Authors:  Benjamin E Turk; Daniel H Lee; Yasuo Yamakoshi; Andreas Klingenhoff; Ernst Reichenberger; J Timothy Wright; James P Simmer; Justin A Komisarof; Lewis C Cantley; John D Bartlett
Journal:  Biochemistry       Date:  2006-03-28       Impact factor: 3.162

7.  MMP20-generated amelogenin cleavage products prevent formation of fan-shaped enamel malformations.

Authors:  John D Bartlett; Charles E Smith; Yuanyuan Hu; Atsushi Ikeda; Mike Strauss; Tian Liang; Ya-Hsiang Hsu; Amanda H Trout; David W McComb; Rebecca C Freeman; James P Simmer; Jan C-C Hu
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

Review 8.  Dental enamel development: proteinases and their enamel matrix substrates.

Authors:  John D Bartlett
Journal:  ISRN Dent       Date:  2013-09-16

9.  Kallikrein 4 and matrix metalloproteinase-20 immunoexpression in malignant, benign and infiltrative odontogenic tumors.

Authors:  Marcelo Macedo Crivelini; Denise Tostes Oliveira; Ricardo Alves de Mesquita; Suzana Cantanhede Orsini Machado de Sousa; Adriano Motta Loyola
Journal:  J Oral Maxillofac Pathol       Date:  2016 May-Aug

10.  Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.

Authors:  J T Korpi; V Kervinen; H Mäklin; A Väänänen; M Lahtinen; E Läärä; A Ristimäki; G Thomas; M Ylipalosaari; P Aström; C Lopez-Otin; T Sorsa; S Kantola; E Pirilä; T Salo
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.